Friday, August 3, 2018

Bitcoin holds steady at $7,500; Coinbase makes inroads into U.K. market

Bitcoin looked to stop the rot Thursday, trading marginally higher in early trading in New York.

After a stellar July, the No. 1 digital has logged four consecutive losing days��something it hasn��t done in five months��putting a dent in its recent momentum.

However, U.K. analyst Nigel Green believes the selloff is temporary. While bitcoin ��might not have reached its 200-day moving average on the topside, cryptocurrency markets do fluctuate more than traditional ones,�� said Green in an email to MarketWatch. ��We assume this is just a temporary drop and we can expect the price to rise again shortly.��

After briefly dipping below $7,500 late Wednesday, bitcoin BTCUSD, +1.02% �has moved into positive territory, last trading at $7,581.31, up 1.3% since Wednesday 5 p.m. on the Kraken exchange.

Read: Bitcoin mining poses threat to Paris climate-change accord, study finds

Coinbase customers can now transact in GBP

Cryptocurrency exchange Coinbase announced Wednesday its customers can now make deposits and withdrawals in British pounds making it easier and more attractive for U.K. clients to trade on the popular San Francisco-based exchange.

Customers in the U.K. previously had to transact in foreign currencies meaning longer delivery time and additional foreign exchange fees.

��Until now, the process of converting bitcoin, bitcoin cash, ethereum and litecoin into euros and then into pound sterling, via international bank transfer, took several days. Customers will now be able to transfer pound sterling and use it to directly buy and sell these cryptocurrencies,�� said Coinbase.

Read: A total collapse in bitcoin is a real possibility, says Nobel Prize��winning economist Krugman

Futures off to a quiet start

Altcoins, or coins other than bitcoin, are mostly higher Thursday. Ether ETHUSD, +1.14% was up 1.5% at $415.52, Bitcoin Cash BCHUSD, +0.66% is trading higher by 0.8%, at $749.50, Litecoin LTCUSD, +0.50% has added 0.9% to $76.58 and Ripple��s XRP XRPUSD, -0.69% coin is down 0.4% at 44 cents.

Bitcoin futures are off to a slow start. The Cboe Global Markets Inc. contract XBTQ8, +0.33% �is up 0.5% at $7,565 and the CME Group Inc.��s August contract BTCQ8, -0.13% is down 0.1% at $7,535.

CryptoWatch: Check bitcoin and other cryptocurrency prices, performance and market capitalization��all on one

Providing critical information for the U.S. trading day. Subscribe to MarketWatch's free Need to Know newsletter. Sign up here.

Aaron Hankin

Aaron Hankin is a MarketWatch reporter in New York who covers cryptocurrency and financial markets.

We Want to Hear from You

Join the conversation

Comment Quote References BTCUSD +76.59 +1.02% ETHUSD +4.67 +1.14% BCHUSD +4.90 +0.66% LTCUSD +0.38 +0.50% XRPUSD +0.00 -0.69% XBTQ8 +25.00 +0.33% BTCQ8 -10.00 -0.13% Show all references MarketWatch Partner Center Most Popular Amazon��s Jeff Bezos would need to spend $28 million a day to avoid getting richer Warren Buffett likely just made more than $2.6 billion, thanks to soaring Apple shares

Wednesday, August 1, 2018

JPMorgan Chase & Co. Reiterates “€72.00” Price Target for Gerresheimer (GXI)

JPMorgan Chase & Co. set a €72.00 ($84.71) price objective on Gerresheimer (ETR:GXI) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

A number of other research firms have also issued reports on GXI. Kepler Capital Markets set a €65.00 ($76.47) price target on shares of Gerresheimer and gave the company a sell rating in a report on Thursday, July 12th. Goldman Sachs Group set a €70.00 ($82.35) price target on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, July 12th. Commerzbank set a €68.00 ($80.00) price target on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, July 12th. equinet set a €69.00 ($81.18) price target on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, July 12th. Finally, Hauck & Aufhaeuser set a €52.50 ($61.76) price target on shares of Gerresheimer and gave the company a sell rating in a report on Monday, July 16th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. Gerresheimer presently has an average rating of Hold and an average price target of €70.13 ($82.50).

Get Gerresheimer alerts:

GXI stock opened at €74.05 ($87.12) on Wednesday. Gerresheimer has a 52-week low of €59.97 ($70.55) and a 52-week high of €78.25 ($92.06).

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Recommended Story: Book Value Of Equity Per Share �� BVPS Explained

Analyst Recommendations for Gerresheimer (ETR:GXI)